PubMed
open access
From consent to participatory governance: The need for multi-stakeholder alignment in iPSC-based drug repurposing.
Induced pluripotent stem cells (iPSCs) are increasingly used as disease models to accelerate drug repurposing, especially for rare diseases. While ethical and regulatory issues in iPSC research have been widely discussed, little is known about how these challenges are addressed in practice. To provi
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Direct Reprogramming and Ethics in Stem Cell Research#704076
- The Drug Repurposing Ecosystem: Intellectual Property Incentives, Market Exclusivity, and the Future of "New" Medicines#271045
- Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening.#335939
- Human stem cell-based embryo models: innovation, ethics, and policy#284395
- Human stem cell-based embryo models: innovation, ethics, and policy.#258338
Record · ID 1330636
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive